Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2006, Article ID 83672, 12 pages
http://dx.doi.org/10.1155/JBB/2006/83672
Review Article

L1 Retrotransposons in Human Cancers

Department of Urology, Heinrich Heine University, Mooreustrasse 5, Düsseldorf 40225, Germany

Received 31 August 2005; Accepted 16 October 2005

Copyright © 2006 Wolfgang A. Schulz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J A Yoder, C P Walsh, and T H Bestor, “Cytosine methylation and the ecology of intragenomic parasites,” Trends in Genetics, vol. 13, no. 8, pp. 335–340, 1997. View at Publisher · View at Google Scholar · View at PubMed
  2. E M Ostertag and H H Jr Kazazian, “Biology of mammalian L1 retrotransposons,” Annual Review of Genetics, vol. 35, pp. 501–538, 2001. View at Publisher · View at Google Scholar · View at PubMed
  3. H H Jr Kazazian, “Mobile elements: drivers of genome evolution,” Science, vol. 303, no. 5664, pp. 1626–1632, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. N Bannert and R Kurth, “Retroelements and the human genome: new perspectives on an old relation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. suppl 2, pp. 14572–14579, 2004. View at Publisher · View at Google Scholar · View at PubMed
  5. D E Symer, C Connelly, S T Szak et al., “Human l1 retrotransposition is associated with genetic instability in vivo,” Cell, vol. 110, no. 3, pp. 327–338, 2002. View at Publisher · View at Google Scholar · View at PubMed
  6. S Boissinot, A Entezam, L Young, P J Munson, and A V Furano, “The insertional history of an active family of L1 retrotransposons in humans,” Genome Research, vol. 14, no. 7, pp. 1221–1231, 2004. View at Publisher · View at Google Scholar · View at PubMed
  7. D Gisselsson, “Chromosome instability in cancer: how, when, and why?,” Advances in Cancer Research, vol. 87, pp. 1–29, 2003. View at Publisher · View at Google Scholar · View at PubMed
  8. G D Swergold, “Identification, characterization, and cell specificity of a human LINE-1 promoter,” Molecular and Cellular Biology, vol. 10, no. 12, pp. 6718–6729, 1990. View at Google Scholar · View at PubMed
  9. C Steinhoff and W A Schulz, “Transcriptional regulation of the human LINE-1 retrotransposon L1.2B,” Molecular Genetics and Genomics, vol. 270, no. 5, pp. 394–402, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. S E Holmes, B A Dombroski, C M Krebs, C D Boehm, and H H Jr Kazazian, “A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion,” Nature Genetics, vol. 7, no. 2, pp. 143–148, 1994. View at Publisher · View at Google Scholar · View at PubMed
  11. J S Han, S T Szak, and J D Boeke, “Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes,” Nature, vol. 429, no. 6989, pp. 268–274, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. L N van de Lagemaat, J R Landry, D L Mager, and P Medstrand, “Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions,” Trends in Genetics, vol. 19, no. 10, pp. 530–536, 2003. View at Publisher · View at Google Scholar · View at PubMed
  13. S Mi, X Lee, X-P Li et al., “Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis,” Nature, vol. 403, no. 6771, pp. 785–789, 2000. View at Publisher · View at Google Scholar · View at PubMed
  14. V Schramke and R Allshire, “Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing,” Science, vol. 301, no. 5636, pp. 1069–1074, 2003. View at Publisher · View at Google Scholar · View at PubMed
  15. Z Lippman, A-V Gendrel, M Black et al., “Role of transposable elements in heterochromatin and epigenetic control,” Nature, vol. 430, no. 6998, pp. 471–476, 2004. View at Publisher · View at Google Scholar · View at PubMed
  16. A Athanasiadis, A Rich, and S Maas, “Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome,” PLoS Biology, vol. 2, no. 12, p. e391, 2004. View at Publisher · View at Google Scholar · View at PubMed
  17. D D Kim, T T Kim, T Walsh et al., “Widespread RNA editing of embedded Alu elements in the human transcriptome,” Genome Research, vol. 14, no. 9, pp. 1719–1725, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. E Y Levanon, E Eisenberg, R Yelin et al., “Systematic identification of abundant A-to-I editing sites in the human transcriptome,” Nature Biotechnology, vol. 22, no. 8, pp. 1001–1005, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. P Turelli, S Vianin, and D Trono, “The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay,” The Journal of Biological Chemistry, vol. 279, no. 42, pp. 43371–43373, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. M Speek, “Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes,” Molecular and Cellular Biology, vol. 21, no. 6, pp. 1973–1985, 2001. View at Publisher · View at Google Scholar · View at PubMed
  21. P Nigumann, K Redik, K Mätlik, and M Speek, “Many human genes are transcribed from the antisense promoter of L1 retrotransposon,” Genomics, vol. 79, no. 5, pp. 628–634, 2002. View at Publisher · View at Google Scholar · View at PubMed
  22. G J Cost, A Golding, M S Schlissel, and J D Boeke, “Target DNA chromatinization modulates nicking by L1 endonuclease,” Nucleic Acids Research, vol. 29, no. 2, pp. 573–577, 2001. View at Publisher · View at Google Scholar · View at PubMed
  23. G J Cost, Q Feng, A Jacquier, and J D Boeke, “Human L1 element target-primed reverse transcription in vitro,” The EMBO Journal, vol. 21, no. 21, pp. 5899–5910, 2002. View at Publisher · View at Google Scholar · View at PubMed
  24. O Weichenrieder, K Repanas, and A Perrakis, “Crystal structure of the targeting endonuclease of the human LINE-1 retrotransposon,” Structure, vol. 12, no. 6, pp. 975–986, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. J S Myers, B J Vincent, H Udall et al., “A comprehensive analysis of recently integrated human Ta L1 elements,” American Journal of Human Genetics, vol. 71, no. 2, pp. 312–326, 2002. View at Publisher · View at Google Scholar · View at PubMed
  26. M Kajikawa and N Okada, “LINEs mobilize SINEs in the eel through a shared 3' sequence,” Cell, vol. 111, no. 3, pp. 433–444, 2002. View at Publisher · View at Google Scholar · View at PubMed
  27. C R Hagan, R F Sheffield, and C M Rudin, “Human Alu element retrotransposition induced by genotoxic stress,” Nature Genetics, vol. 35, no. 3, pp. 219–220, 2003. View at Publisher · View at Google Scholar · View at PubMed
  28. W Wei, N Gilbert, S L Ooi et al., “Human L1 retrotransposition: cis preference versus trans complementation,” Molecular and Cellular Biology, vol. 21, no. 4, pp. 1429–1439, 2001. View at Publisher · View at Google Scholar · View at PubMed
  29. I Sciamanna, M Landriscina, C Pittoggi et al., “Inhibition of endogenous reverse transcriptase antagonizes human tumor growth,” Oncogene, vol. 24, no. 24, pp. 3923–3931, 2005. View at Publisher · View at Google Scholar · View at PubMed
  30. E S Lander, L M Linton, B Birren et al., “Initial sequencing and analysis of the human genome,” Nature, vol. 409, no. 6822, pp. 860–921, 2001. View at Publisher · View at Google Scholar · View at PubMed
  31. M T Ross, D V Grafham, A J Coffey et al., “The DNA sequence of the human X chromosome,” Nature, vol. 434, no. 7031, pp. 325–337, 2005. View at Publisher · View at Google Scholar · View at PubMed
  32. J A Bailey, L Carrel, A Chakravarti, and E E Eichler, “Molecular evidence for a relationship between LINE-1 elements and X chromosome inactivation: the Lyon repeat hypothesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6634–6639, 2000. View at Publisher · View at Google Scholar · View at PubMed
  33. R S Hansen, “X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis,” Human Molecular Genetics, vol. 12, no. 19, pp. 2559–2567, 2003. View at Publisher · View at Google Scholar · View at PubMed
  34. A M Laurent, J Puechberty, C Prades, S Gimenez, and G Roizès, “Site-specific retrotransposition of L1 elements within human alphoid satellite sequences,” Genomics, vol. 46, no. 1, pp. 127–132, 1997. View at Publisher · View at Google Scholar · View at PubMed
  35. N N Khodarev, T Bennett, N Shearing et al., “LINE L1 retrotransposable element is targeted during the initial stages of apoptotic DNA fragmentation,” Journal of Cellular Biochemistry, vol. 79, no. 3, pp. 486–495, 2000. View at Publisher · View at Google Scholar · View at PubMed
  36. S Raschke, V Balz, T Efferth, W A Schulz, and A R Florl, “Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines,” Genes, Chromosomes and Cancer, vol. 42, no. 1, pp. 58–67, 2005. View at Publisher · View at Google Scholar · View at PubMed
  37. T H Li and C W Schmid, “Differential stress induction of individual Alu loci: implications for transcription and retrotransposition,” Gene, vol. 276, no. 1-2, pp. 135–141, 2001. View at Publisher · View at Google Scholar · View at PubMed
  38. C R Hagan and C M Rudin, “Mobile genetic element activation and genotoxic cancer therapy: potential clinical implications,” American Journal of PharmacoGenomics, vol. 2, no. 1, pp. 25–35, 2002. View at Publisher · View at Google Scholar · View at PubMed
  39. G Banerjee, N Gupta, J Tiwari, and G Raman, “Ultraviolet-induced transformation of keratinocytes: possible involvement of long interspersed element-1 reverse transcriptase,” Photodermatology, Photoimmunology & Photomedicine, vol. 21, no. 1, pp. 32–39, 2005. View at Google Scholar · View at PubMed
  40. C A Seemayer, O Distler, S Kuchen et al., “Rheumatoide Arthritis: Neue Entwicklungen in der Pathogeneses unter besonderer Berücksichtigung der synovialen Fibroblasten [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts],” Zeitschrift für Rheumatologie, vol. 60, no. 5, pp. 309–318, 2001. View at Google Scholar · View at PubMed
  41. M Neidhart, J Rethage, S Kuchen et al., “Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression,” Arthritis & Rheumatism, vol. 43, no. 12, pp. 2634–2647, 2000. View at Google Scholar · View at PubMed
  42. S Kuchen, C A Seemayer, J Rethage et al., “The L1 retroelement-related p40 protein induces p38delta MAP kinase,” Autoimmunity, vol. 37, no. 1, pp. 57–65, 2004. View at Publisher · View at Google Scholar · View at PubMed
  43. W A Schulz, C Steinhoff, and A R Florl, “Methylation of endogenous human retroelements in health and disease,” Current Topics in Microbiology and Immunology. 2006; 310, in press.
  44. V Armbruester, M Sauter, E Krautkraemer et al., “A novel gene from the human endogenous retrovirus K expressed in transformed cells,” Clinical Cancer Research, vol. 8, no. 6, pp. 1800–1807, 2002. View at Google Scholar · View at PubMed
  45. F Schiavetti, J Thonnard, D Colau, T Boon, and P G Coulie, “A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes,” Cancer Research, vol. 62, no. 19, pp. 5510–5516, 2002. View at Google Scholar · View at PubMed
  46. G Alves, M T Kawamura, P Nascimento et al., “DNA release by line-1 (L1) retrotransposon. Could it be possible?,” Annals of the New York Academy of Sciences, vol. 906, pp. 129–133, 2000. View at Google Scholar · View at PubMed
  47. L G Shaffer and J R Lupski, “Molecular mechanisms for constitutional chromosomal rearrangements in humans,” Annual Review of Genetics, vol. 34, pp. 297–329, 2000. View at Publisher · View at Google Scholar · View at PubMed
  48. I Ovchinnikov, A Rubin, and G D Swergold, “Tracing the LINEs of human evolution,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10522–10527, 2002. View at Publisher · View at Google Scholar · View at PubMed
  49. P A Jones and S B Baylin, “The fundamental role of epigenetic events in cancer,” Nature Reviews. Genetics, vol. 3, no. 6, pp. 415–428, 2002. View at Publisher · View at Google Scholar · View at PubMed
  50. M Ehrlich, “DNA methylation in cancer: too much, but also too little,” Oncogene, vol. 21, no. 35, pp. 5400–5413, 2002. View at Publisher · View at Google Scholar · View at PubMed
  51. M J Hoffmann and W A Schulz, “Causes and consequences of DNA hypomethylation in human cancer,” Biochemistry and Cell Biology, vol. 83, no. 3, pp. 296–321, 2005. View at Publisher · View at Google Scholar · View at PubMed
  52. A Kaneda, T Tsukamoto, T Takamura-Enya et al., “Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation,” Cancer Science, vol. 95, no. 1, pp. 58–64, 2004. View at Publisher · View at Google Scholar · View at PubMed
  53. G L Bratthauer and T G Fanning, “Active LINE-1 retrotransposons in human testicular cancer,” Oncogene, vol. 7, no. 3, pp. 507–510, 1992. View at Google Scholar · View at PubMed
  54. J Skowronski, T G Fanning, and M F Singer, “Unit-length line-1 transcripts in human teratocarcinoma cells,” Molecular and Cellular Biology, vol. 8, no. 4, pp. 1385–1397, 1988. View at Google Scholar · View at PubMed
  55. R Dante, J Dante-Paire, D Rigal, and G Roizes, “Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors,” Anticancer Research, vol. 12, no. 2, pp. 559–563, 1992. View at Google Scholar · View at PubMed
  56. K Chalitchagorn, S Shuangshoti, N Hourpai et al., “Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis,” Oncogene, vol. 23, no. 54, pp. 8841–8846, 2004. View at Publisher · View at Google Scholar · View at PubMed
  57. A R Florl, R Löwer, B J Schmitz-Dräger, and W A Schulz, “DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas,” British Journal of Cancer, vol. 80, no. 9, pp. 1312–1321, 1999. View at Publisher · View at Google Scholar · View at PubMed
  58. B Jurgens, B J Schmitz-Drager, and W A Schulz, “Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma,” Cancer Research, vol. 56, no. 24, pp. 5698–5703, 1996. View at Google Scholar · View at PubMed
  59. W A Schulz, J P Elo, A R Florl et al., “Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma,” Genes, Chromosomes and Cancer, vol. 35, no. 1, pp. 58–65, 2002. View at Publisher · View at Google Scholar · View at PubMed
  60. A R Florl, C Steinhoff, M Müller et al., “Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation,” British Journal of Cancer, vol. 91, no. 5, pp. 985–994, 2004. View at Google Scholar · View at PubMed
  61. S Santourlidis, A R Florl, R Ackermann, H C Wirtz, and W A Schulz, “High frequency of alterations in DNA methylation in adenocarcinoma of the prostate,” The Prostate, vol. 39, no. 3, pp. 166–174, 1999. View at Publisher · View at Google Scholar · View at PubMed
  62. D Takai, Y Yagi, N Habib, T Sugimura, and T Ushijima, “Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis,” Japanese Journal of Clinical Oncology, vol. 30, no. 7, pp. 306–309, 2000. View at Publisher · View at Google Scholar · View at PubMed
  63. C-H Lin, S-Y Hsieh, I-S Sheen et al., “Genome-wide hypomethylation in hepatocellular carcinogenesis,” Cancer Research, vol. 61, no. 10, pp. 4238–4243, 2001. View at Google Scholar · View at PubMed
  64. C M Suter, D I Martin, and R L Ward, “Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue,” International Journal of Colorectal Disease, vol. 19, no. 2, pp. 95–101, 2004. View at Publisher · View at Google Scholar · View at PubMed
  65. L Menendez, B B Benigno, and J F McDonald, “L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas,” Molecular Cancer, vol. 3, no. 1, p. 12, 2004. View at Publisher · View at Google Scholar · View at PubMed
  66. A S Yang, M R Estécio, K Doshi, Y Kondo, E H Tajara, and J-P J Issa, “A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements,” Nucleic Acids Research, vol. 32, no. 3, p. e38, 2004. View at Publisher · View at Google Scholar · View at PubMed
  67. D J Smiraglia, J Szymanska, S M Kraggerud, R A Lothe, P Peltomäki, and C Plass, “Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors,” Oncogene, vol. 21, no. 24, pp. 3909–3916, 2002. View at Publisher · View at Google Scholar · View at PubMed
  68. J W Oosterhuis and L H Looijenga, “Testicular germ-cell tumours in a broader perspective,” Nature Reviews. Cancer, vol. 5, no. 3, pp. 210–222, 2005. View at Publisher · View at Google Scholar · View at PubMed
  69. G Alves, A Tatro, and T G Fanning, “Differential methylation of human LINE-1 retrotransposons in malignant cells,” Gene, vol. 176, no. 1-2, pp. 39–44, 1996. View at Publisher · View at Google Scholar · View at PubMed
  70. N Gotzinger, M Sauter, K Roemer, and N Mueller-Lantzsch, “Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours,” Journal of General Virology, vol. 77, no. pt 12, pp. 2983–2990, 1996. View at Google Scholar · View at PubMed
  71. A F Burden, N C Manley, A D Clark, S M Gartler, C D Laird, and R S Hansen, “Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements,” The Journal of Biological Chemistry, vol. 280, no. 15, pp. 14413–14419, 2005. View at Publisher · View at Google Scholar · View at PubMed
  72. M Weber, J J Davies, D Wittig et al., “Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells,” Nature Genetics, vol. 37, no. 8, pp. 853–862, 2005. View at Publisher · View at Google Scholar · View at PubMed
  73. M S Turker, “Gene silencing in mammalian cells and the spread of DNA methylation,” Oncogene, vol. 21, no. 35, pp. 5388–5393, 2002. View at Publisher · View at Google Scholar · View at PubMed
  74. E Li, “Chromatin modification and epigenetic reprogramming in mammalian development,” Nature Reviews. Genetics, vol. 3, no. 9, pp. 662–673, 2002. View at Publisher · View at Google Scholar · View at PubMed
  75. T H Bestor, “The DNA methyltransferases of mammals,” Human Molecular Genetics, vol. 9, no. 16, pp. 2395–2402, 2000. View at Publisher · View at Google Scholar · View at PubMed
  76. D Bourc'his and T H Bestor, “Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L,” Nature, vol. 431, no. 7004, pp. 96–99, 2004. View at Google Scholar · View at PubMed
  77. J Huang, T Fan, Q Yan et al., “Lsh, an epigenetic guardian of repetitive elements,” Nucleic Acids Research, vol. 32, no. 17, pp. 5019–5028, 2004. View at Publisher · View at Google Scholar · View at PubMed
  78. R J Gibbons, T L McDowell, S Raman et al., “Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation,” Nature Genetics, vol. 24, no. 4, pp. 368–371, 2000. View at Publisher · View at Google Scholar · View at PubMed
  79. R Ferreira, I Naguibneva, L L Pritchard, S Ait-Si-Ali, and A Harel-Bellan, “The Rb/chromatin connection and epigenetic control: opinion,” Oncogene, vol. 20, no. 24, pp. 3128–3133, 2001. View at Publisher · View at Google Scholar · View at PubMed
  80. T M Geiman and K D Robertson, “Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?,” Journal of Cellular Biochemistry, vol. 87, no. 2, pp. 117–125, 2002. View at Publisher · View at Google Scholar · View at PubMed
  81. A H Lund and M van Lohuizen, “Epigenetics and cancer,” Genes & Development, vol. 18, no. 19, pp. 2315–2335, 2004. View at Google Scholar · View at PubMed
  82. M F Fraga, E Ballestar, A Villar-Garea et al., “Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer,” Nature Genetics, vol. 37, no. 4, pp. 391–400, 2005. View at Publisher · View at Google Scholar · View at PubMed
  83. D B Seligson, S Horvath, T Shi et al., “Global histone modification patterns predict risk of prostate cancer recurrence,” Nature, vol. 435, no. 7046, pp. 1262–1266, 2005. View at Publisher · View at Google Scholar · View at PubMed
  84. J H Martens, R J O'Sullivan, U Braunschweig et al., “The profile of repeat-associated histone lysine methylation states in the mouse epigenome,” The EMBO Journal, vol. 24, no. 4, pp. 800–812, 2005. View at Publisher · View at Google Scholar · View at PubMed
  85. F Wang-Johanning, A R Frost, B Jian et al., “Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma,” Cancer, vol. 98, no. 1, pp. 187–197, 2003. View at Publisher · View at Google Scholar · View at PubMed
  86. K Büscher, U Trefzer, M Hofmann, W Sterry, R Kurth, and J Denner, “Expression of human endogenous retrovirus K in melanomas and melanoma cell lines,” Cancer Research, vol. 65, no. 10, pp. 4172–4180, 2005. View at Google Scholar · View at PubMed
  87. J Sugimoto, N Matsuura, Y Kinjo, N Takasu, T Oda, and Y Jinno, “Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping,” Genomics, vol. 72, no. 2, pp. 137–144, 2001. View at Publisher · View at Google Scholar · View at PubMed
  88. J-M Yi, H-M Kim, and H-S Kim, “Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells,” Journal of General Virology, vol. 85, no. pt 5, pp. 1203–1210, 2004. View at Publisher · View at Google Scholar · View at PubMed
  89. S Ergün, C Buschmann, J Heukeshoven et al., “Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues,” The Journal of Biological Chemistry, vol. 279, no. 26, pp. 27753–27763, 2004. View at Google Scholar · View at PubMed
  90. B Morse, P G Rotherg, V J South, J M Spandorfer, and S M Astrin, “Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma,” Nature, vol. 333, no. 6168, pp. 87–90, 1988. View at Publisher · View at Google Scholar · View at PubMed
  91. Y Miki, I Nishisho, A Horii et al., “Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer,” Cancer Research, vol. 52, no. 3, pp. 643–645, 1992. View at Google Scholar · View at PubMed
  92. T A Morrish, N Gilbert, J S Myers et al., “DNA repair mediated by endonuclease-independent LINE-1 retrotransposition,” Nature Genetics, vol. 31, no. 2, pp. 159–165, 2002. View at Publisher · View at Google Scholar · View at PubMed
  93. J Liu, M M Nau, J Zucman-Rossi, J I Powell, C J Allegra, and J J Wright, “LINE-I element insertion at the t(11;22) translocation breakpoint of a desmoplastic small round cell tumor,” Genes, Chromosomes and Cancer, vol. 18, no. 3, pp. 232–239, 1997. View at Publisher · View at Google Scholar · View at PubMed
  94. A R Florl, K H Franke, D Niederacher, C D Gerharz, H H Seifert, and W A Schulz, “DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder,” Laboratory Investigation, vol. 80, no. 10, pp. 1513–1522, 2000. View at Google Scholar · View at PubMed
  95. G Z Qu, P E Grundy, A Narayan, and M Ehrlich, “Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16,” Cancer Genetics and Cytogenetics, vol. 109, no. 1, pp. 34–39, 1999. View at Publisher · View at Google Scholar · View at PubMed
  96. N Wong, W C Lam, P B Lai, E Pang, W Y Lau, and P J Johnson, “Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma,” The American Journal of Pathology, vol. 159, no. 2, pp. 465–471, 2001. View at Google Scholar · View at PubMed
  97. M Widschwendter, G Jiang, C Woods et al., “DNA hypomethylation and ovarian cancer biology,” Cancer Research, vol. 64, no. 13, pp. 4472–4480, 2004. View at Publisher · View at Google Scholar · View at PubMed
  98. K Mimori, T Druck, H Inoue et al., “Cancer-specific chromosome alterations in the constitutive fragile region FRA3B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7456–7461, 1999. View at Publisher · View at Google Scholar · View at PubMed
  99. A R Florl and W A Schulz, “Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells,” Genes, Chromosomes and Cancer, vol. 37, no. 2, pp. 141–148, 2003. View at Publisher · View at Google Scholar · View at PubMed
  100. C Cox, G Bignell, C Greenman et al., “A survey of homozygous deletions in human cancer genomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 12, pp. 4542–4547, 2005. View at Publisher · View at Google Scholar · View at PubMed
  101. R S Jones and S S Potter, “L1 sequences in HeLa extrachromosomal circular DNA: evidence for circularization by homologous recombination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 7, pp. 1989–1993, 1985. View at Publisher · View at Google Scholar · View at PubMed
  102. H Huang, J Qian, J Proffit, K Wilber, R Jenkins, and D I Smith, “FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites,” Oncogene, vol. 16, no. 18, pp. 2311–2319, 1998. View at Publisher · View at Google Scholar · View at PubMed
  103. S Sasaki, Y Kitagawa, Y Sekido et al., “Molecular processes of chromosome 9p21 deletions in human cancers,” Oncogene, vol. 22, no. 24, pp. 3792–3798, 2003. View at Publisher · View at Google Scholar · View at PubMed
  104. T Varga and P D Aplan, “Chromosomal aberrations induced by double strand DNA breaks,” DNA Repair, vol. 4, no. 9, pp. 1038–1046, 2005. View at Publisher · View at Google Scholar · View at PubMed
  105. A Viel, F Petronzelli, P Della Puppa et al., “Different molecular mechanisms underlie genomic deletions in the MLH1 Gene,” Human Mutation, vol. 20, no. 5, pp. 368–374, 2002. View at Publisher · View at Google Scholar · View at PubMed
  106. J Adams, S V Williams, J S Aveyard, and M A Knowles, “Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss,” Cancer Research, vol. 65, no. 1, pp. 66–75, 2005. View at Google Scholar · View at PubMed
  107. G A Calin, C Sevignani, C D Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at PubMed
  108. Y Kondo and J P Issa, “Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells,” The Journal of Biological Chemistry, vol. 278, no. 30, pp. 27658–27662, 2003. View at Publisher · View at Google Scholar · View at PubMed
  109. A Haoudi, O J Semmes, J M Mason, and R E Cannon, “Retrotransposition-competent human LINE-1 induces apoptosis in cancer cells with intact p53,” Journal of Biomedicine and Biotechnology, vol. 2004, no. 4, pp. 185–194, 2004. View at Publisher · View at Google Scholar · View at PubMed